# IBANDRONATE SODIUM
> **ANDA206058** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2016-02-05
## Drug
- **FDA Application Number:** ANDA206058
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBANDRONATE SODIUM
- **Generic name:** Ibandronate Sodium
- **Active ingredients:** IBANDRONATE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ACCORD HLTHCARE
- **First approval:** 2016-02-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206058)
---
*MORVS · CC0 1.0*